{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T19:36:38Z","timestamp":1783625798459,"version":"3.55.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2019,5,14]],"date-time":"2019-05-14T00:00:00Z","timestamp":1557792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,5,14]],"date-time":"2019-05-14T00:00:00Z","timestamp":1557792000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Foundation of Korea","doi-asserted-by":"crossref","award":["NRF-2016R1A2B4007282"],"award-info":[{"award-number":["NRF-2016R1A2B4007282"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1007\/s00277-019-03714-x","type":"journal-article","created":{"date-parts":[[2019,5,14]],"date-time":"2019-05-14T08:03:42Z","timestamp":1557821022000},"page":"1743-1753","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Risk factors predicting graft-versus-host disease and relapse-free survival after allogeneic hematopoietic stem cell transplantation in relapsed or refractory non-Hodgkin\u2019s lymphoma"],"prefix":"10.1007","volume":"98","author":[{"given":"Young-Woo","family":"Jeon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seugyun","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gi June","family":"Min","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung-Soo","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae-Ho","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung-Eun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byung-Sik","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ki-Seong","family":"Eom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoo-Jin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hee-Je","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seok","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-Ki","family":"Min","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong Wook","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5429-4839","authenticated-orcid":false,"given":"Seok-Goo","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,14]]},"reference":[{"issue":"12","key":"3714_CR1","doi-asserted-by":"publisher","first-page":"3725","DOI":"10.1182\/blood-2005-01-0016","volume":"106","author":"W Hiddemann","year":"2005","unstructured":"Hiddemann W, Kneba M, Dreyling M, Schmitz N, Lengfelder E, Schmits R, Reiser M, Metzner B, Harder H, Hegewisch-Becker S, Fischer T, Kropff M, Reis HE, Freund M, Wormann B, Fuchs R, Planker M, Schimke J, Eimermacher H, Trumper L, Aldaoud A, Parwaresch R, Unterhalt M (2005) Frontline therapy with rituximab added to the combination of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) significantly improves the outcome for patients with advanced-stage follicular lymphoma compared with therapy with CHOP alone: results of a prospective randomized study of the German Low-Grade Lymphoma Study Group. Blood 106(12):3725\u20133732. \n                    https:\/\/doi.org\/10.1182\/blood-2005-01-0016","journal-title":"Blood"},{"key":"3714_CR2","doi-asserted-by":"publisher","unstructured":"Pfreundschuh M, Kuhnt E, Trumper L, Osterborg A, Trneny M, Shepherd L, Gill DS, Walewski J, Pettengell R, Jaeger U, Zinzani PL, Shpilberg O, Kvaloy S, de Nully Brown P, Stahel R, Milpied N, Lopez-Guillermo A, Poeschel V, Grass S, Loeffler M, Murawski N, MabThera International Trial G (2011) CHOP-like chemotherapy with or without rituximab in young patients with good-prognosis diffuse large-B-cell lymphoma: 6-year results of an open-label randomised study of the MabThera International Trial (MInT) Group. Lancet Oncol 12 (11):1013\u20131022. doi:\n                    https:\/\/doi.org\/10.1016\/S1470-2045(11)70235-2","DOI":"10.1016\/S1470-2045(11)70235-2"},{"issue":"10","key":"3714_CR3","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1038\/sj.bmt.1700989","volume":"20","author":"T Tsai","year":"1997","unstructured":"Tsai T, Goodman S, Saez R, Schiller G, Adkins D, Callander N, Wolff S, Freytes CO (1997) Allogeneic bone marrow transplantation in patients who relapse after autologous transplantation. Bone Marrow Transplant 20(10):859\u2013863. \n                    https:\/\/doi.org\/10.1038\/sj.bmt.1700989","journal-title":"Bone Marrow Transplant"},{"key":"3714_CR4","doi-asserted-by":"publisher","unstructured":"Cheah CY, Fowler NH, Wang ML (2016) Breakthrough therapies in B-cell non-Hodgkin lymphoma. Annals of oncology : official journal of the European society for Med Oncol 27 (5):778\u2013787. doi:\n                    https:\/\/doi.org\/10.1093\/annonc\/mdw029","DOI":"10.1093\/annonc\/mdw029"},{"issue":"4","key":"3714_CR5","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.hemonc.2017.05.004","volume":"10","author":"N Epperla","year":"2017","unstructured":"Epperla N, Hamadani M (2017) Hematopoietic cell transplantation for diffuse large B-cell and follicular lymphoma: current controversies and advances. Hematol Oncol Stem Cell Ther 10(4):277\u2013284. \n                    https:\/\/doi.org\/10.1016\/j.hemonc.2017.05.004","journal-title":"Hematol Oncol Stem Cell Ther"},{"issue":"1","key":"3714_CR6","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1182\/blood.V99.1.75","volume":"99","author":"P Corradini","year":"2002","unstructured":"Corradini P, Tarella C, Olivieri A, Gianni AM, Voena C, Zallio F, Ladetto M, Falda M, Lucesole M, Dodero A, Ciceri F, Benedetti F, Rambaldi A, Sajeva MR, Tresoldi M, Pileri A, Bordignon C, Bregni M (2002) Reduced-intensity conditioning followed by allografting of hematopoietic cells can produce clinical and molecular remissions in patients with poor-risk hematologic malignancies. Blood 99(1):75\u201382","journal-title":"Blood"},{"issue":"4","key":"3714_CR7","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.bbmt.2013.01.009","volume":"19","author":"M Hamadani","year":"2013","unstructured":"Hamadani M, Saber W, Ahn KW, Carreras J, Cairo MS, Fenske TS, Gale RP, Gibson J, Hale GA, Hari PN, Hsu JW, Inwards DJ, Kamble RT, Klein A, Maharaj D, Marks DI, Rizzieri DA, Savani BN, Schouten HC, Waller EK, Wirk B, Lazarus HM (2013) Allogeneic hematopoietic cell transplantation for chemotherapy-unresponsive mantle cell lymphoma: a cohort analysis from the center for international blood and marrow transplant research. Biol Blood Marrow Transplant 19(4):625\u2013631. \n                    https:\/\/doi.org\/10.1016\/j.bbmt.2013.01.009","journal-title":"Biol Blood Marrow Transplant"},{"issue":"9","key":"3714_CR8","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1016\/j.bbmt.2016.04.019","volume":"22","author":"TS Fenske","year":"2016","unstructured":"Fenske TS, Hamadani M, Cohen JB, Costa LJ, Kahl BS, Evens AM, Hamlin PA, Lazarus HM, Petersdorf E, Bredeson C (2016) Allogeneic hematopoietic cell transplantation as curative therapy for patients with non-Hodgkin lymphoma: increasingly successful application to older patients. Biol Blood Marrow Transplant 22(9):1543\u20131551. \n                    https:\/\/doi.org\/10.1016\/j.bbmt.2016.04.019","journal-title":"Biol Blood Marrow Transplant"},{"issue":"3","key":"3714_CR9","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1182\/blood-2014-02-514778","volume":"124","author":"B Gyurkocza","year":"2014","unstructured":"Gyurkocza B, Sandmaier BM (2014) Conditioning regimens for hematopoietic cell transplantation: one size does not fit all. Blood 124(3):344\u2013353. \n                    https:\/\/doi.org\/10.1182\/blood-2014-02-514778","journal-title":"Blood"},{"issue":"8","key":"3714_CR10","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1182\/blood-2014-10-609032","volume":"125","author":"SG Holtan","year":"2015","unstructured":"Holtan SG, DeFor TE, Lazaryan A, Bejanyan N, Arora M, Brunstein CG, Blazar BR, MacMillan ML, Weisdorf DJ (2015) Composite end point of graft-versus-host disease-free, relapse-free survival after allogeneic hematopoietic cell transplantation. Blood 125(8):1333\u20131338. \n                    https:\/\/doi.org\/10.1182\/blood-2014-10-609032","journal-title":"Blood"},{"issue":"6","key":"3714_CR11","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1016\/j.bbmt.2018.01.002","volume":"24","author":"MC Pasquini","year":"2018","unstructured":"Pasquini MC, Logan B, Jones RJ, Alousi AM, Appelbaum FR, Bolanos-Meade J, Flowers MED, Giralt S, Horowitz MM, Jacobsohn D, Koreth J, Levine JE, Luznik L, Maziarz R, Mendizabal A, Pavletic S, Perales MA, Porter D, Reshef R, Weisdorf D, Antin JH (2018) Blood and marrow transplant clinical trials network report on the development of novel endpoints and selection of promising approaches for graft-versus-host disease prevention trials. Biol Blood Marrow Transplant 24(6):1274\u20131280. \n                    https:\/\/doi.org\/10.1016\/j.bbmt.2018.01.002","journal-title":"Biol Blood Marrow Transplant"},{"issue":"3","key":"3714_CR12","first-page":"83","volume":"102","author":"E Sabattini","year":"2010","unstructured":"Sabattini E, Bacci F, Sagramoso C, Pileri SA (2010) WHO classification of tumours of haematopoietic and lymphoid tissues in 2008: an overview. Pathologica 102(3):83\u201387","journal-title":"Pathologica"},{"issue":"7","key":"3714_CR13","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1016\/j.bbmt.2008.04.003","volume":"14","author":"D Weisdorf","year":"2008","unstructured":"Weisdorf D, Spellman S, Haagenson M, Horowitz M, Lee S, Anasetti C, Setterholm M, Drexler R, Maiers M, King R, Confer D, Klein J (2008) Classification of HLA-matching for retrospective analysis of unrelated donor transplantation: revised definitions to predict survival. Biol Blood Marrow Transplant 14(7):748\u2013758. \n                    https:\/\/doi.org\/10.1016\/j.bbmt.2008.04.003","journal-title":"Biol Blood Marrow Transplant"},{"issue":"6","key":"3714_CR14","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/bmt.2011.110","volume":"47","author":"A Gratwohl","year":"2012","unstructured":"Gratwohl A (2012) The EBMT risk score. Bone Marrow Transplant 47(6):749\u2013756. \n                    https:\/\/doi.org\/10.1038\/bmt.2011.110","journal-title":"Bone Marrow Transplant"},{"issue":"17","key":"3714_CR15","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1056\/NEJM197504242921706","volume":"292","author":"ED Thomas","year":"1975","unstructured":"Thomas ED, Storb R, Clift RA, Fefer A, Johnson L, Neiman PE, Lerner KG, Glucksberg H, Buckner CD (1975) Bone-marrow transplantation (second of two parts). N Engl J Med 292(17):895\u2013902. \n                    https:\/\/doi.org\/10.1056\/NEJM197504242921706","journal-title":"N Engl J Med"},{"issue":"3","key":"3714_CR16","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.bbmt.2014.12.001","volume":"21","author":"MH Jagasia","year":"2015","unstructured":"Jagasia MH, Greinix HT, Arora M, Williams KM, Wolff D, Cowen EW, Palmer J, Weisdorf D, Treister NS, Cheng GS, Kerr H, Stratton P, Duarte RF, McDonald GB, Inamoto Y, Vigorito A, Arai S, Datiles MB, Jacobsohn D, Heller T, Kitko CL, Mitchell SA, Martin PJ, Shulman H, Wu RS, Cutler CS, Vogelsang GB, Lee SJ, Pavletic SZ, Flowers ME (2015) National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. The 2014 Diagnosis and Staging Working Group report. Biol Blood Marrow Transplant 21(3):389\u2013401 e381. \n                    https:\/\/doi.org\/10.1016\/j.bbmt.2014.12.001","journal-title":"Biol Blood Marrow Transplant"},{"issue":"3","key":"3714_CR17","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/bmt.2012.244","volume":"48","author":"Y Kanda","year":"2013","unstructured":"Kanda Y (2013) Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics. Bone Marrow Transplant 48(3):452\u2013458. \n                    https:\/\/doi.org\/10.1038\/bmt.2012.244","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"3714_CR18","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1038\/bmt.2015.305","volume":"51","author":"A Ruggeri","year":"2016","unstructured":"Ruggeri A, Labopin M, Ciceri F, Mohty M, Nagler A (2016) Definition of GvHD-free, relapse-free survival for registry-based studies: an ALWP-EBMT analysis on patients with AML in remission. Bone Marrow Transplant 51(4):610\u2013611. \n                    https:\/\/doi.org\/10.1038\/bmt.2015.305","journal-title":"Bone Marrow Transplant"},{"key":"3714_CR19","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1016\/j.bbmt.2018.02.004","volume":"24","author":"K Kawamura","year":"2018","unstructured":"Kawamura K, Nakasone H, Kurosawa S, Yoshimura K, Misaki Y, Gomyo A, Hayakawa J, Tamaki M, Akahoshi Y, Kusuda M, Kameda K, Wada H, Ishihara Y, Sato M, Terasako-Saito K, Kikuchi M, Kimura SI, Tanihara A, Kako S, Kanamori H, Mori T, Takahashi S, Taniguchi S, Atsuta Y, Kanda Y (2018) Refractory graft-versus-host disease-free, relapse-free survival as an accurate and easy-to-calculate endpoint to assess the long-term transplant success. Biol Blood Marrow Transplant 24:1521\u20131526. \n                    https:\/\/doi.org\/10.1016\/j.bbmt.2018.02.004","journal-title":"Biol Blood Marrow Transplant"},{"issue":"7","key":"3714_CR20","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1016\/j.bbmt.2017.03.031","volume":"23","author":"A Dodero","year":"2017","unstructured":"Dodero A, Patriarca F, Milone G, Sarina B, Miceli R, Iori A, Barretta F, Terruzzi E, Mussetti A, Pini M, Bosi A, Dominietto A, Cascavilla N, Onida F, Narni F, Farina L, Rambaldi A, Corradini P (2017) Allogeneic stem cell transplantation for relapsed\/refractory B cell lymphomas: results of a multicenter phase II prospective trial including rituximab in the reduced-intensity conditioning regimen. Biol Blood Marrow Transplant 23(7):1102\u20131109. \n                    https:\/\/doi.org\/10.1016\/j.bbmt.2017.03.031","journal-title":"Biol Blood Marrow Transplant"},{"key":"3714_CR21","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1038\/bmt.2016.349","volume":"52","author":"J Gauthier","year":"2017","unstructured":"Gauthier J, Castagna L, Garnier F, Guillaume T, Socie G, Maury S, Maillard N, Tabrizi R, Marchand T, Malfuson J, Gac A, Gyan E, Mercier M, Beguin Y, Delage J, Turlure P, Marcais A, Nguyen S, Dulery R, Bay J, Huynh A, Daguindau E, Cornillon J, Regny C, Michallet M, Peffault de Latour R, Yakoub-Agha I, Blaise D (2017) Reduced-intensity and non-myeloablative allogeneic stem cell transplantation from alternative HLA-mismatched donors for Hodgkin lymphoma: a study by the French Society of Bone Marrow Transplantation and Cellular Therapy. Bone Marrow Transplant 52:689\u2013696. \n                    https:\/\/doi.org\/10.1038\/bmt.2016.349","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"3714_CR22","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/j.bbmt.2017.11.003","volume":"24","author":"BM William","year":"2018","unstructured":"William BM, Wang T, Haagenson MD, Fleischhauer K, Verneris M, Hsu KC, de Lima MJ, Fernandez-Vina M, Spellman SR, Lee SJ, Hill BT (2018) Impact of HLA alleles on outcomes of allogeneic transplantation for B cell non-Hodgkin lymphomas: a Center for International Blood and Marrow Transplant Research analysis. Biol Blood Marrow Transplant 24(4):827\u2013831. \n                    https:\/\/doi.org\/10.1016\/j.bbmt.2017.11.003","journal-title":"Biol Blood Marrow Transplant"},{"key":"3714_CR23","doi-asserted-by":"publisher","unstructured":"Cudillo L, Cerretti R, Picardi A, Mariotti B, De Angelis G, Cantonetti M, Postorino M, Ceresoli E, De Santis G, Nasso D, Pisani F, Scala E, Di Piazza F, Lanti A, William Arcese for the Rome transplant N (2018) Allogeneic hematopoietic stem cell transplantation in primary cutaneous T cell lymphoma. Ann Hematol 97 (6):1041\u20131048. \n                    https:\/\/doi.org\/10.1007\/s00277-018-3275-z\n                    \n                  , 2018","DOI":"10.1007\/s00277-018-3275-z"},{"issue":"7","key":"3714_CR24","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/j.bbmt.2008.04.014","volume":"14","author":"S Shiratori","year":"2008","unstructured":"Shiratori S, Yasumoto A, Tanaka J, Shigematsu A, Yamamoto S, Nishio M, Hashino S, Morita R, Takahata M, Onozawa M, Kahata K, Kondo T, Ota S, Wakasa K, Sugita J, Koike T, Asaka M, Kasai M, Imamura M (2008) A retrospective analysis of allogeneic hematopoietic stem cell transplantation for adult T cell leukemia\/lymphoma (ATL): clinical impact of graft-versus-leukemia\/lymphoma effect. Biol Blood Marrow Transplant 14(7):817\u2013823. \n                    https:\/\/doi.org\/10.1016\/j.bbmt.2008.04.014","journal-title":"Biol Blood Marrow Transplant"},{"issue":"12","key":"3714_CR25","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1200\/JCO.2012.45.0247","volume":"31","author":"R Storb","year":"2013","unstructured":"Storb R, Gyurkocza B, Storer BE, Sorror ML, Blume K, Niederwieser D, Chauncey TR, Pulsipher MA, Petersen FB, Sahebi F, Agura ED, Hari P, Bruno B, McSweeney PA, Maris MB, Maziarz RT, Langston AA, Bethge W, Vindelov L, Franke GN, Laport GG, Yeager AM, Hubel K, Deeg HJ, Georges GE, Flowers ME, Martin PJ, Mielcarek M, Woolfrey AE, Maloney DG, Sandmaier BM (2013) Graft-versus-host disease and graft-versus-tumor effects after allogeneic hematopoietic cell transplantation. J Clin Oncol 31(12):1530\u20131538. \n                    https:\/\/doi.org\/10.1200\/JCO.2012.45.0247","journal-title":"J Clin Oncol"},{"key":"3714_CR26","doi-asserted-by":"publisher","first-page":"2794","DOI":"10.1158\/1078-0432.CCR-17-3622","volume":"24","author":"F Baron","year":"2018","unstructured":"Baron F, Labopin M, Ruggeri A, Cornelissen JJ, Meijer E, Sengeloev H, Niederwieser D, de Groot MR, Schouten HC, Milpied NJ, Blaise D, Savani B, Gluckman E, Mohty M, Nagler A (2018) Impact of donor type in patients with AML given allogeneic hematopoietic cell transplantation after low-dose TBI based regimen. Clin Cancer Res 24:2794\u20132803. \n                    https:\/\/doi.org\/10.1158\/1078-0432.CCR-17-3622","journal-title":"Clin Cancer Res"},{"issue":"17","key":"3714_CR27","doi-asserted-by":"publisher","first-page":"2859","DOI":"10.1200\/JCO.2009.27.1460","volume":"28","author":"B Gyurkocza","year":"2010","unstructured":"Gyurkocza B, Storb R, Storer BE, Chauncey TR, Lange T, Shizuru JA, Langston AA, Pulsipher MA, Bredeson CN, Maziarz RT, Bruno B, Petersen FB, Maris MB, Agura E, Yeager A, Bethge W, Sahebi F, Appelbaum FR, Maloney DG, Sandmaier BM (2010) Nonmyeloablative allogeneic hematopoietic cell transplantation in patients with acute myeloid leukemia. J Clin Oncol 28(17):2859\u20132867. \n                    https:\/\/doi.org\/10.1200\/JCO.2009.27.1460","journal-title":"J Clin Oncol"},{"issue":"7","key":"3714_CR28","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1016\/j.bbmt.2017.02.022","volume":"23","author":"SR Solomon","year":"2017","unstructured":"Solomon SR, Sizemore C, Zhang X, Ridgeway M, Solh M, Morris LE, Holland HK, Bashey A (2017) Current graft-versus-host disease-free, relapse-free survival: a dynamic endpoint to better define efficacy after allogenic transplant. Biol Blood Marrow Transplant 23(7):1208\u20131214. \n                    https:\/\/doi.org\/10.1016\/j.bbmt.2017.02.022","journal-title":"Biol Blood Marrow Transplant"},{"issue":"8","key":"3714_CR29","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1016\/j.bbmt.2016.04.006","volume":"22","author":"M Solh","year":"2016","unstructured":"Solh M, Zhang X, Connor K, Brown S, Solomon SR, Morris LE, Holland HK, Bashey A (2016) Factors predicting graft-versus-host disease-free, relapse-free survival after allogeneic hematopoietic cell transplantation: multivariable analysis from a single center. Biol Blood Marrow Transplant 22(8):1403\u20131409. \n                    https:\/\/doi.org\/10.1016\/j.bbmt.2016.04.006","journal-title":"Biol Blood Marrow Transplant"},{"issue":"7","key":"3714_CR30","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1182\/blood-2015-09-671834","volume":"127","author":"AS Kanate","year":"2016","unstructured":"Kanate AS, Mussetti A, Kharfan-Dabaja MA, Ahn KW, DiGilio A, Beitinjaneh A, Chhabra S, Fenske TS, Freytes C, Gale RP, Ganguly S, Hertzberg M, Klyuchnikov E, Lazarus HM, Olsson R, Perales MA, Rezvani A, Riches M, Saad A, Slavin S, Smith SM, Sureda A, Yared J, Ciurea S, Armand P, Salit R, Bolanos-Meade J, Hamadani M (2016) Reduced-intensity transplantation for lymphomas using haploidentical related donors vs HLA-matched unrelated donors. Blood 127(7):938\u2013947. \n                    https:\/\/doi.org\/10.1182\/blood-2015-09-671834","journal-title":"Blood"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-019-03714-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-019-03714-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-019-03714-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,12]],"date-time":"2020-05-12T23:07:21Z","timestamp":1589324841000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-019-03714-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,14]]},"references-count":30,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["3714"],"URL":"https:\/\/doi.org\/10.1007\/s00277-019-03714-x","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,14]]},"assertion":[{"value":"19 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Institutional Review Board (IRB) of Seoul St. Mary\u2019s Hospital, the Catholic University of Korea in accordance with the Declaration of Helsinki. The informed consent was obtained from all the participants included in this study as per the guidelines of our IRB.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}